Insulet (PODD) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $143.34 -2.12%
Financial Fact:
Other expense, net: -5.37M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Other expense, net: -5.37M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q2 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $177.1 million versus the consensus estimate of $163.66 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
